SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-015840
Filing Date
2023-09-18
Accepted
2023-09-18 08:00:25
Documents
25
Period of Report
2023-09-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20230918x8k.htm   iXBRL 8-K 41541
2 EX-99.1 acrs-20230918xex99d1.htm EX-99.1 13111
3 EX-99.2 acrs-20230918xex99d2.htm EX-99.2 20176
4 GRAPHIC acrs-20230918xex99d1001.jpg GRAPHIC 8905
5 GRAPHIC acrs-20230918xex99d2g001.jpg GRAPHIC 175955
6 GRAPHIC acrs-20230918xex99d2g002.jpg GRAPHIC 302780
7 GRAPHIC acrs-20230918xex99d2g003.jpg GRAPHIC 221083
8 GRAPHIC acrs-20230918xex99d2g004.jpg GRAPHIC 211982
9 GRAPHIC acrs-20230918xex99d2g005.jpg GRAPHIC 175510
10 GRAPHIC acrs-20230918xex99d2g006.jpg GRAPHIC 154246
11 GRAPHIC acrs-20230918xex99d2g007.jpg GRAPHIC 196783
12 GRAPHIC acrs-20230918xex99d2g008.jpg GRAPHIC 192592
13 GRAPHIC acrs-20230918xex99d2g009.jpg GRAPHIC 201326
14 GRAPHIC acrs-20230918xex99d2g010.jpg GRAPHIC 154787
  Complete submission text file 0001558370-23-015840.txt   2958132

Data Files

Seq Description Document Type Size
15 EX-101.SCH acrs-20230918.xsd EX-101.SCH 3135
16 EX-101.LAB acrs-20230918_lab.xml EX-101.LAB 15916
17 EX-101.PRE acrs-20230918_pre.xml EX-101.PRE 10223
19 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20230918x8k_htm.xml XML 4840
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 231260127
SIC: 2834 Pharmaceutical Preparations